Enablex
Product Images NDC 54868-5704

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Enablex (NDC 54868-5704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Enablex (darifenacin) Structural Formula (Enablex 03)

Enablex (darifenacin) Structural Formula (Enablex 03)
FDA Label Image

Figure 1 Mean (sd) Steady State Darifenacin Plasma Concentration Time Profiles For Enablex® 7.5 And 15 mg In Healthy Volunteers Including Both Cyp2d6 Ems And Pms* (Enablex 04)

Figure 1 Mean (sd) Steady State Darifenacin Plasma Concentration Time Profiles For Enablex® 7.5 And 15 mg In Healthy Volunteers Including Both Cyp2d6 Ems And Pms* (Enablex 04)
FDA Label Image

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2a, Study 1 (Enablex 05)

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2a, Study 1 (Enablex 05)
FDA Label Image

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2b, Study 2 (Enablex 06)

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2b, Study 2 (Enablex 06)
FDA Label Image

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2c, Study 3 (Enablex 07)

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2c, Study 3 (Enablex 07)
FDA Label Image

Principal Display Panel (7.5 mg)

Principal Display Panel (7.5 mg)
This is a label or tag for a product called "ENABLER 7.5K6" that was distributed by "PHYSICIANS TOTAL CARE". The label includes a lot number and expiration date, but not much else is provided. No other information is available from this text.*
FDA Label Image

Principal Display Panel (15 mg)

Principal Display Panel (15 mg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.